Virtus Investment Advisers, Inc. Ionis Pharmaceuticals Inc Transaction History
Virtus Investment Advisers, Inc.
- $289 Million
- Q1 2025
A detailed history of Virtus Investment Advisers, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 9,701 shares of IONS stock, worth $409,770. This represents 0.1% of its overall portfolio holdings.
Number of Shares
9,701Holding current value
$409,770% of portfolio
0.1%Shares
1 transactions
Others Institutions Holding IONS
# of Institutions
402Shares Held
145MCall Options Held
916KPut Options Held
552K-
Vanguard Group Inc Valley Forge, PA16.4MShares$692 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.2MShares$683 Million0.32% of portfolio
-
Capital World Investors Los Angeles, CA12.4MShares$522 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$436 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.42MShares$356 Million0.05% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $6B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...